For Immediate Release
Chicago, IL – July 12, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co.
JPM
, Intel Corporation
INTC
, McDonald’s Corporation
MCD
, CME Group Inc.
CME
and Gilead Sciences, Inc.
GILD
.
Here are highlights from Friday’s Analyst Blog:
Top Stock Reports for JPMorgan, Intel and McDonald’s
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including JPMorgan, Intel, and McDonald’s. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
all of today’s research reports here >>>
Shares of
JPMorgan
have modestly underperformed the Zacks Major Regional Banks industry in the year-to-date period (+21% vs. +23%), likely reflective of the company’s relative less interest rate sensitivity. The Zacks analyst believes that strategic inorganic expansion initiatives, strong mortgage banking business as well as branch openings in new regions are likely to keep aiding the financials in the near term. JPMorgan is on track to report strong June-quarter results ahead of the market’s open on Tuesday (7/13).
While robust economic recovery is expected to increase the demand for loans, coronavirus-induced economic downturn will continue to hurt the same. The Federal Reserve’s accommodative policy and near-zero rates are likely to hamper interest income and margins, going forward.
(You can
read the full research report on JPMorgan here >>>
)
Intel
shares have gained +9.6% over the last six months against the Zacks General Semiconductor industry’s gain of +26.1%. The Zacks analyst believes that sluggish data center demand across cloud service providers, enterprise and government end-markets is likely to hurt the data center business.
Declining average selling price (ASPs), weakness in Internet of Things (IoT) end-markets and production delays remain other major headwinds. Nonetheless, Intel is likely to benefit from higher demand for its 10 nanometer (nm) SuperFin process-based 11th Gen core processors, on the back of remote working and online learning wave amid robust growth in PC market.
(You can
read the full research report on Intel here >>>
)
Shares of
McDonald’s
have gained +2.3% in the past three months against the Zacks Restaurants industry industry’s gain of +1.9%. The Zacks analyst believes that the company’s increased focus on drive-thru, delivery & take-away bodes well.
Recently, McDonald’s launched its first-ever loyalty program in the United States, and it is expected to drive average checks. During first-quarter 2021, the company recorded nearly $1.5 billion in digital sales, which includes app, kiosks and delivery. However, France and Germany reported dismal comps due to dining rooms closures and curfews.
(You can
read the full research report on McDonald’s here >>>
)
Other noteworthy reports we are featuring today include CME Group and Gilead Sciences.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released
Century of Biology: 7 Biotech Stocks to Buy Right Now
to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
